| 0.4 | - | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 5 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 24 | - | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 24 | - | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 40 | mg/kg bw/day | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 40 | % | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 40 | mg/kg bw/day | - | - | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw/day | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 100 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 107 | mg/kg bw | - | - | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 107 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 115 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 115 | mg/kg bw | - | oral | dog | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 132 | mg/kg bw | - | oral | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 286.7 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 27.998 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 32.63 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 92.79 | ug/mL | CV70 | Dermal | - | NTP_ICE_skin_sensitization |
| 396 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 0.5 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.4167 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| =0.04 | mg/m3 | DNEL local | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =2.96 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 56.5 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 68.2 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 26.7 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 67.8 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 47 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 62.15 | % | Depletion Lys + Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 24.58 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 77 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 80.41 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 87 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 88.6 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 89.1 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 89.12 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 91.7 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 95.6 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 100.92 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 107.53 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 115.89 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 116.87 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 120 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 123.92 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 127.41 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 127.64 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 130.5 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |
| 131.2 | uM | EC1.5 | Dermal | - | NTP_ICE_skin_sensitization |